A weight-loss injection which suppresses the appetite is now available at all Boots and Lloyds Pharmacy branches.
After Britain was confirmed as the most obese nation in Europe, the jab – which is named Saxenda, or is sometimes referred to as Liraglutide – is intended to suppress a person’s appetite and works by mimicking a hormone called GLP1, which is the hormone that is released after you eat to let you know you’re full.
When combined with a low-fat food plan and moderate levels of activity, users of Saxenda should expect to lose 5% of their body weight over three months.
It is not recommended if you’re pregnant or breastfeeding, or have certain health conditions, such as liver or kidney problems.
ADVERTISEMENT
Users of Saxenda should expect to lose 5% of their body weight over three months / Credit: Saxenda | Novo Nordisk
On Saxenda’s website, it says that common side effects for those taking the injection include nausea, tiredness, constipation and low blood sugar, among other things, and among the serious side effects it lists “thyroid tumours, including cancer”.
It is important to note, however, Saxenda is a weight-loss aid and not a cure that works without major dietary and lifestyle changes.
ADVERTISEMENT
First approved in the UK in 2017 and initially only available through private prescription, Saxenda was recently rolled out on the NHS under strict criteria, which means that to get access to the jab at the likes of Boots and Lloyds Pharmacy, you will have take an online questionnaire and match such criteria that changes depending on the individual.
Saxenda is now available at all Boots and Lloyds Pharmacy branches / Credit: Flickr
In most cases, you have to be 30 or above on the Body Mass Index (BMI) scale and have tried other methods of losing weight before being accepted for Saxenda.
During the online consultation, you will be asked about your medical history and symptoms, and your answers help assess your suitability for treatment.
ADVERTISEMENT
If accepted, you can pick up your jabs in store or have them delivered for free to your home. Saxenda comes in a 3ml pre-filled injection pen, with a single pen lasting 17 days and a pack of three covering 4.5 weeks.
A pack of three pens costs £150 and a pack of five is priced at £240.
Saxenda® (liraglutide 3mg) is a once daily prescription medicine and always needs to be prescribed by a licensed healthcare professional.
Boots Saxenda® prescriptions are issued by a doctor and collected in store. Lloyds pharmacy dispense their prescriptions under a Patient Group Directions (PGD). PGD’s are documents in the U.K. National Health Service that permit the supply of prescription-only medicines to groups of patients, without individual prescriptions.
New endometriosis pill helping hundreds of women with ‘debilitating’ condition to be made available on NHS
Emily Sergeant
A groundbreaking new pill to help women with a ‘debilitating’ condition is set to be made available on the NHS.
The new daily pill for endometriosis – which has been approved for use on the NHS in England by the National Institute for Health and Care Excellence (NICE) – is called linzagolix, and will be available for those who have had previous treatment for endometriosis, working to manage any symptoms they may be experiencing.
Around 1.5 million women in the UK are thought to be currently living with endometriosis.
Endometriosis can cause chronic pain, heavy periods, and extreme tiredness when tissue similar to the womb lining grows elsewhere in the body.
A new daily pill for endometriosis has been approved for use on the NHS, and could help over a thousand women in England every year manage the symptoms of the debilitating condition.
As mentioned, linzagolix will be available specifically for patients whose previous medical or surgical treatments for endometriosis have been unsuccessful, and will be given alongside ‘add-back’ hormone therapy – which involves using low-dose hormone replacement therapy (HRT) to prevent menopause-like symptoms and bone loss.
This is the second take-at-home treatment to be approved to treat endometriosis on the NHS, and it’s thought that more than 1,000 women will benefit.
In clinical trials, linzagolix was shown to be successful in reducing painful periods and non-menstrual pelvic pain, compared with placebo, hence why it has been approved on the NHS by NICE.
“This is welcome news for women with endometriosis who haven’t found relief from previous therapies or surgery,” commented Dr Sue Mann, who is the National Clinical Director in Women’s Health for NHS England.
“It’s another treatment option which will help women take control of their health and better manage the symptoms of this often painful and debilitating condition.
“This is a testament to our ongoing commitment to improving treatment, care and quality of life for women.”
Featured Image – Heute
News
Wigan woman jailed after hitting pedestrian in Fiat 500 while driving high on nitrous oxide ‘balloons’
Emily Sergeant
A young woman from Wigan has been handed jail time after hitting a pedestrian while driving high on nitrous oxide.
Louisa Tunstall was driving a white Fiat 500 towards the East Lancashire Road in Wigan at around 7pm on Friday 24 May 2024 – a time when traffic conditions were said to be ‘quiet’ – but Tunstall was under the influence of a now-banned drug, nitrous oxide, at the time of the incident, Greater Manchester Police (GMP) confirmed.
While driving under the influence, 19-year-old Tunstall veered to the left onto the pavement and collided with a 51-year-old woman pedestrian.
After striking the woman, the car then overturned and, in the process, caused serious life-changing injuries.
When questioned by police, Tunstall stated that she ‘took her eyes off the road’ to retrieve something in the footwell before knowing the car had flipped, but she also confirmed that she had just been out to purchase nitrous oxide to use that evening.
After obtaining witness accounts, investigating officers were able to track down nearby CCTV footable which showed Tunstall inhaling nitrous oxide through a balloon whilst driving, seconds before the collision occurred.
#JAILED | It's not a laughing matter when you get behind the wheel under the influence of drugs.
Now Louisa Tunstall has to spend over a year behind bars after inhaling nitrous oxide and causing serious injury in #Wigan last year.
— Greater Manchester Police (@gmpolice) May 14, 2025
Further investigation by GMP’s Forensic Vehicle Examination Unit examined the Fiat 500 and confirmed that no defects were found on the car to contribute towards the collision.
Still to this day, the victim says she is trying to recover from the injuries sustained to her leg that will prevent her from continuing life as she did before.
“The incident is still very raw when I think about it,” the victim explained in her impact statement released by GMP. “I become upset when I think at everything which has been taken away from me and the ongoing affect it has had and continues to have on my daily life.”
GMP says it’s seeing the use of nitrous oxide being a factor in incidents they attend increasing year on year.
Nitrous oxide, also known as ‘laughing gas’, is reported to produce euphoria, relaxation, dizziness, giggling or laughing fits, impaired judgement, and occasionally dissociation and hallucinations – which GMP says affects reaction time and and is ‘likely lead to impairment’ in driving performance, particularly when faced with an unexpected or hazardous situation.
Tunstall appeared at Bolton Crown Court this week, and has been sentenced to one year and eight months imprisonment for having possession of a Class C drug, driving under the influence of drugs, and causing serious injury by dangerous driving.
Alongside being jailed, she was also disqualified from driving for two years and eight months, and has been ordered to take an extended test when she is released.
Emily Sergeant -
7th March 2022 
